Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 11/2019

01-11-2019 | Genitourinary Syndrome of Menopause | Original Article

The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue

Authors: Sasivimol Srisukho, Tawiwan Pantasri, Wirawit Piyamongkol, Chailert Phongnarisorn, Nuntana Morakote

Published in: International Urogynecology Journal | Issue 11/2019

Login to get access

Abstract

Genitourinary syndrome of menopause (GSM) is common among postmenopausal women, but, in general, not all of the patients seek medical advice as this sensitive issue can cause them embarrassment.

Objectives

To explore the prevalence of GSM among Thai postmenopausal women and their disclosure of and attitude towards GSM.

Methods

A questionnaire was used to obtain information on GSM from 499 Thai postmenopausal women who attended the Menopause Clinic at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, from November 2015 to August 2016.

Results

The mean age of the 499 participants was 57.8 ± 7.2 years. It was notable that 87.2% of them had had GSM, and the prevalence increased with age. The most common symptoms were nocturia (77.7%) and vaginal dryness (51.7%). Among the symptomatic patients, 63.0% conveyed their problem to other people, i.e., friends and family, while 52.9% of them never reported to health care providers. The most common reason for not talking about their GSM was the acceptance of it being part of the natural aging process.

Conclusions

GSM is common among Thai postmenopausal women. The prevalence of non-reporting is high and underreported.
Appendix
Available only for authorised users
Literature
1.
Chua Y, Limpaphayom KK, Cheng B, Ho CM, Sumapradja K, Altomare C, et al. Genitourinary syndrome of menopause in five Asian countries: results from the pan-Asian REVIVE survey. Climacteric. 2017;20(4):367–73.CrossRef
2.
Moral E, Delgado JL, Carmona F, Caballero B, Guillan C, Gonzalez PM, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21(2):167–73.CrossRef
3.
Portman DJ, Gass ML. Vulvovaginal atrophy terminology consensus conference P. genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's sexual health and the North American Menopause Society. Maturitas. 2014;79(3):349–54.CrossRef
4.
Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–11.CrossRef
5.
DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Women's Health (Larchmt). 2015;24(9):713–22.CrossRef
6.
Indhavivadhana S, Leerasiri P, Rattanachaiyanont M, Laiwejpithaya S, Tanmahasamut P, Techatraisak K, et al. Vaginal atrophy and sexual dysfunction in current users of systemic postmenopausal hormone therapy. J Med Assoc Thail. 2010;93(6):667–75.
7.
Pinkerton JV, Bushmakin AG, Komm BS, Abraham L. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Maturitas. 2017;100:57–63.CrossRef
8.
Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA)—results from an international survey. Climacteric. 2012;15(1):36–44.CrossRef
9.
Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–8.CrossRef
10.
Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85(1):87–94.CrossRef
11.
Kowalcek I, Rotte D, Banz C, Diedrich K. Women's attitude and perceptions towards menopause in different cultures. Cross-cultural and intra-cultural comparison of pre-menopausal and post-menopausal women in Germany and in Papua New Guinea. Maturitas. 2005;51(3):227–35.CrossRef
12.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Am J Obstet Gynecol. 2002;187(1):116–26.CrossRef
13.
Palacios S, Castelo-Branco C, Currie H, Mijatovic V, Nappi RE, Simon J, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82(3):308–13.CrossRef
14.
Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 2000;86(1):32–8.CrossRef
15.
Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011;30(5):754–7.CrossRef
16.
Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. Int Urogynecol J. 2012;23(8):975–82.CrossRef
17.
Cervigni M, Gambacciani M. Female urinary stress incontinence. Climacteric. 2015;18(Suppl 1):30–6.CrossRef
18.
Erekson EA, Li FY, Martin DK, Fried TR. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016;23(4):368–75.PubMedPubMedCentral
19.
Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6(8):2133–42.CrossRef
20.
Huang KE, Xu L, I NN, Jaisamrarn U. The Asian menopause survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas. 2010;65(3):276–83.CrossRef
21.
Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas. 2009;63(2):138–41.CrossRef
22.
Dennerstein L, Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause. 2004;11(6 Pt 2):778–85.CrossRef
23.
Chedraui P, Perez-Lopez FR, San Miguel G, Avila C. Assessment of sexuality among middle-aged women using the female sexual function index. Climacteric. 2009;12(3):213–21.CrossRef
24.
Peeyananjarassri K, Liabsuetrakul T, Soonthornpun K, Choobun T, Manopsilp P. Sexual functioning in postmenopausal women not taking hormone therapy in the gynecological and menopause clinic, Songklanagarind Hospital measured by female sexual function index questionnaire. J Med Assoc Thail. 2008;91(5):625–32.
25.
Sturdee DW, Panay N. International menopause society writing G. recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22.CrossRef
26.
Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:CD001405.PubMed
27.
Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293(8):935–48.CrossRef
28.
Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril. 2006;85(1):155–60.CrossRef
29.
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;2:CD005131.
30.
Iglesia CB. What's new in the world of postmenopausal sex? Curr Opin Obstet Gynecol. 2016;28(5):449–54.CrossRef
Metadata
Title
The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue
Authors
Sasivimol Srisukho
Tawiwan Pantasri
Wirawit Piyamongkol
Chailert Phongnarisorn
Nuntana Morakote
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
International Urogynecology Journal / Issue 11/2019
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-019-03991-0

Other articles of this Issue 11/2019

International Urogynecology Journal 11/2019 Go to the issue

Original Article

Incidence and contributing factors of perioperative complications in surgical procedures for pelvic organ prolapse

Original Article

Variation in bony landmarks and predictors of success with sacral neuromodulation

Original Article

Comparing the effectiveness of functional electrical stimulation via sexual cognitive/behavioral therapy of pelvic floor muscles versus local injection of botulinum toxin on the sexual functioning of patients with primary vaginismus: a randomized clinical trial

Original Article

Robot-assisted laparoscopic sacrocolpopexy with autologous fascia lata: technique and initial outcomes

Review Article

Biomarkers in the diagnosis and symptom assessment of patients with bladder pain syndrome: a systematic review

Original Article

Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype?